Corporate Update – Zenas Biopharma (ZBIO)
Trading Performance (24‑hour period ending 12:15 AM Central Europe, Wednesday 21 Oct 2026)
| Item | Value |
|---|---|
| Closing price | USD 28.18 |
| Daily change | +7.53 % |
| 24‑hour traded volume | USD 18.6 million |
| Market capitalization | USD 1.6 billion |
| Outstanding shares | 65.2 million |
| Simple moving average (200 days) | USD 24.59 |
| 52‑week high | USD 44.60 (24 Dec 2025) |
| 52‑week low | USD 13.50 (5 Jan 2026) |
The stock has declined −17.94 % relative to the previous month‑end level.
Peer Comparison (24‑hour period)
| Stock | Ticker | Daily change | Current price (USD) | Market cap (USD) | P/E ratio |
|---|---|---|---|---|---|
| Manpowergroup | MAN | −0.02 % | 42.98 | 1.9 billion | 22.31 |
| Innovex | INVX | +0.46 % | 28.46 | 1.9 billion | 31.71 |
| Plug Power | PLUG | −0.72 % | 1.40 | 1.9 billion | – |
| Trulieve Cannabis | TRLV | +2.70 % | 10.79 | 1.9 billion | – |
| Butterfly Network | BFLY | +3.03 % | 7.31 | 1.9 billion | – |
Summary
Zenas Biopharma experienced a significant intraday rise of 7.53 %, bringing its share price to USD 28.18. The company’s market capitalization stands at USD 1.6 billion, with 65.2 million shares outstanding. Over the past 24 hours, USD 18.6 million worth of ZBIO shares were traded, a moderate volume compared with the 200‑day moving average of USD 24.59. The stock remains below its 52‑week high of USD 44.60 and above its 52‑week low of USD 13.50. In comparison, most of the peer group showed modest movements, with Trulieve Cannabis and Butterfly Network posting the largest gains in the same period.
